IBEX Technologies KUV 2025

Какво прави IBEX Technologies?

IBEX Technologies Inc. is a Canadian company founded in 1994. The company develops and distributes laboratory equipment and services for medical diagnostics and research. IBEX Technologies' business model is based on the development, production, and marketing of products in the field of in vitro diagnostics, life sciences, and the pharmaceutical industry. The company's operations include several divisions, including the distribution and manufacture of reagents, enzyme immunoassay kits (EIA kits), and other immunological tests used for disease diagnostics and other applications in the clinical and scientific fields. In addition, the company also produces calibrators and control solutions used to monitor laboratory efficiency, device performance, and laboratory test accuracy. IBEX Technologies primarily supplies customers in North America and Europe, as well as worldwide. An important part of IBEX Technologies' business operations is the field of life sciences. Here, the company develops several products, including recombinant proteins, antibodies, and glycobiochemistry reagents. These products are mainly used in biomedical research and serve to investigate disease-relevant biomolecules and their interactions in living organisms. IBEX Technologies also has a special division called Bio-Research Products, which focuses on research and development in the pharmaceutical and biotechnology fields. Here, new and innovative diagnostic and therapeutic possibilities are developed to improve patient care. The company was founded in 1994 by Canadian entrepreneur Paul Baehr, who is still CEO today. Since its inception, IBEX Technologies has become a globally recognized company in the field of in vitro diagnostics and life sciences. The company's successes are based on an innovative product range and the use of state-of-the-art technologies. IBEX Technologies is headquartered in Montreal, Canada, and has subsidiaries in the USA and Europe. In total, the company employs more than 40 employees worldwide and works closely with industry partners. In summary, IBEX Technologies Inc. is a successful company in the field of in vitro diagnostics and life sciences. Through the development and production of innovative products and the use of state-of-the-art technologies, the company contributes to improving disease diagnostics and treatment. With its versatile product portfolio and international presence, IBEX Technologies is well-positioned to continue growing and strengthen its position in the market. IBEX Technologies ist eines der beliebtesten Unternehmen auf Eulerpool.com.